JP Morgan Maintains Overweight on HCA Healthcare, Raises Price Target to $186

JP Morgan maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $157 to $186.

Benzinga · 12/20/2019 14:34

JP Morgan maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $157 to $186.